Financials

Ono Pharmaceutical: FYE Mar 2026 and ten years of results (45 metrics)

FYE Mar 2026 · Revenue¥516bnYoY +5.9%
FYE Mar 2026 · Operating profit¥92bnYoY +54.4%
FYE Mar 2026 · Net profit¥70bnYoY +39.4%
FYE Mar 2026 · Equity ratio76.3%YoY +3.4pp
FYE Mar 2026 · Group employees4,206YoY −81
Fiscal yearRevenueYoYOperating profitYoYMarginNet profitChief executiveThat year
FYE Mar 2017Consolidated¥245bnn/a¥72bnn/a29.5%¥56bnSagara Gyo
FYE Mar 2018Consolidated¥262bn+7.0%¥61bn−16.0%23.2%¥50bnSagara Gyo
FYE Mar 2019Consolidated¥289bn+10.2%¥62bn+2.2%21.5%¥52bnSagara Gyo
FYE Mar 2020Consolidated¥292bn+1.3%¥77bn+25.0%26.5%¥60bnSagara Gyo
FYE Mar 2021Consolidated¥309bn+5.8%¥98bn+26.9%31.8%¥75bnSagara GyoOno Venture Investment and Fund I set up in the United States
FYE Mar 2022Consolidated¥361bn+16.8%¥103bn+4.9%28.6%¥81bnSagara Gyo
FYE Mar 2023Consolidated¥447bn+23.8%¥142bn+37.6%31.7%¥113bnSagara GyoMoves to the TSE Prime market
FYE Mar 2024Consolidated¥503bn+12.4%¥160bn+12.7%31.8%¥128bnSagara Gyo
FYE Mar 2025Consolidated¥487bn−3.1%¥60bn−62.6%12.3%¥50bnSagara GyoAcquires Deciphera Pharmaceuticals for about $2.4 billion
FYE Mar 2026Consolidated¥516bn+5.9%¥92bn+54.4%17.9%¥70bnTakino Toichi

How it compares

Ono Pharmaceutical¥516bnFY2025Operating margin 17.9%
Santen Pharmaceutical¥292bnFY2025Operating margin 16.4%
Touwayakuhin¥260bnFY2024Operating margin 9.0%
Sawai Group Holdings¥202bnFY2025Operating margin 7.9%
Tsumura¥193bnFY2025Operating margin 18.3%Nippon Shinyaku¥171bnFY2025Operating margin 20.8%Hisamitsu PharmaceuticalDelisted 2026
Asukaseiyakuhorudingusu¥64bnFY2024Operating margin 8.3%

Income statement Revenue, costs, each level of profit and the margins they leave

Where the revenue goes

¥ bn
Cost of sales SG&A Other operating costs Operating profit

Margins

%
Gross margin Operating margin Net margin

Revenue net sales, operating revenue

FYE Mar 2026 ¥516bn
CAGR · 10 yrs +8.6%
Fiscal year Revenue ¥ bn YoY Basis
FYE Mar 2017 245 n/a Cons. · IFRS
FYE Mar 2018 262 +7.0% Cons. · IFRS
FYE Mar 2019 289 +10.2% Cons. · IFRS
FYE Mar 2020 292 +1.3% Cons. · IFRS
FYE Mar 2021 309 +5.8% Cons. · IFRS
FYE Mar 2022 361 +16.8% Cons. · IFRS
FYE Mar 2023 447 +23.8% Cons. · IFRS
FYE Mar 2024 503 +12.4% Cons. · IFRS
FYE Mar 2025 487 −3.1% Cons. · IFRS
FYE Mar 2026 516 +5.9% Cons. · IFRS
Definition
Everything the company took in from its own business
Formula
Revenue line of the income statement
Source
Securities report (XBRL)

Cost of sales

FYE Mar 2026 ¥142bn
CAGR · 10 yrs +8.9%
Fiscal year Cost of sales ¥ bn YoY Basis
FYE Mar 2017 65.5 n/a Cons. · IFRS
FYE Mar 2018 65.4 −0.2% Cons. · IFRS
FYE Mar 2019 83.8 +28.2% Cons. · IFRS
FYE Mar 2020 79.1 −5.7% Cons. · IFRS
FYE Mar 2021 85.6 +8.2% Cons. · IFRS
FYE Mar 2022 93.5 +9.3% Cons. · IFRS
FYE Mar 2023 110 +17.7% Cons. · IFRS
FYE Mar 2024 127 +15.5% Cons. · IFRS
FYE Mar 2025 148 +16.4% Cons. · IFRS
FYE Mar 2026 142 −4.2% Cons. · IFRS
Definition
The cost of what was sold
Formula
Cost of sales line of the income statement
Source
Securities report (XBRL)

Gross profit

FYE Mar 2026 ¥374bn
CAGR · 10 yrs +8.5%
Fiscal year Gross profit ¥ bn YoY Basis
FYE Mar 2017 179 n/a Cons. · IFRS
FYE Mar 2018 196 +9.6% Cons. · IFRS
FYE Mar 2019 205 +4.3% Cons. · IFRS
FYE Mar 2020 213 +4.2% Cons. · IFRS
FYE Mar 2021 224 +4.9% Cons. · IFRS
FYE Mar 2022 268 +19.7% Cons. · IFRS
FYE Mar 2023 337 +25.9% Cons. · IFRS
FYE Mar 2024 376 +11.4% Cons. · IFRS
FYE Mar 2025 339 −9.8% Cons. · IFRS
FYE Mar 2026 374 +10.4% Cons. · IFRS
Definition
What the product or service itself earns
Formula
Revenue − cost of sales
Source
Securities report (XBRL)

SG&A selling, general and administrative expenses

FYE Mar 2026 ¥124bn
CAGR · 10 yrs +8.0%
Fiscal year SG&A ¥ bn YoY Basis
FYE Mar 2017 62.0 n/a Cons. · IFRS
FYE Mar 2018 68.1 +9.7% Cons. · IFRS
FYE Mar 2019 70.0 +2.9% Cons. · IFRS
FYE Mar 2020 67.7 −3.4% Cons. · IFRS
FYE Mar 2021 69.2 +2.3% Cons. · IFRS
FYE Mar 2022 77.1 +11.3% Cons. · IFRS
FYE Mar 2023 89.5 +16.1% Cons. · IFRS
FYE Mar 2024 100 +12.1% Cons. · IFRS
FYE Mar 2025 126 +25.3% Cons. · IFRS
FYE Mar 2026 124 −1.6% Cons. · IFRS
Definition
The cost of selling and of running the company
Formula
SG&A line of the income statement
Source
Securities report (XBRL)

Operating profit

FYE Mar 2026 ¥92bn
CAGR · 10 yrs +2.7%
Fiscal year Operating profit ¥ bn YoY Basis
FYE Mar 2017 72.3 n/a Cons. · IFRS
FYE Mar 2018 60.7 −16.0% Cons. · IFRS
FYE Mar 2019 62.0 +2.2% Cons. · IFRS
FYE Mar 2020 77.5 +25.0% Cons. · IFRS
FYE Mar 2021 98.3 +26.9% Cons. · IFRS
FYE Mar 2022 103 +4.9% Cons. · IFRS
FYE Mar 2023 142 +37.6% Cons. · IFRS
FYE Mar 2024 160 +12.7% Cons. · IFRS
FYE Mar 2025 59.7 −62.6% Cons. · IFRS
FYE Mar 2026 92.2 +54.4% Cons. · IFRS
Definition
What the core business earns
Formula
Gross profit − SG&A
Source
Securities report (XBRL)

Non-operating income

FYE Mar 2026 ¥4.0bn
CAGR · 9 yrs +2.4%
Fiscal year Non-operating income ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 3.3 n/a Cons. · IFRS
FYE Mar 2019 3.3 +0.2% Cons. · IFRS
FYE Mar 2020 3.1 −7.0% Cons. · IFRS
FYE Mar 2021 2.7 −11.8% Cons. · IFRS
FYE Mar 2022 2.7 +0.6% Cons. · IFRS
FYE Mar 2023 2.5 −8.6% Cons. · IFRS
FYE Mar 2024 4.0 +62.5% Cons. · IFRS
FYE Mar 2025 4.8 +18.5% Cons. · IFRS
FYE Mar 2026 4.0 −17.1% Cons. · IFRS
Definition
Income from outside the core business
Formula
Non-operating income line of the income statement
Source
Securities report (XBRL)

Non-operating expenses

FYE Mar 2026 ¥3.5bn
CAGR · 9 yrs +77.4%
Fiscal year Non-operating expenses ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 0.0 n/a Cons. · IFRS
FYE Mar 2019 0.2 +316.7% Cons. · IFRS
FYE Mar 2020 0.8 +463.3% Cons. · IFRS
FYE Mar 2021 0.1 −83.8% Cons. · IFRS
FYE Mar 2022 0.9 +538.0% Cons. · IFRS
FYE Mar 2023 0.9 +4.5% Cons. · IFRS
FYE Mar 2024 0.2 −74.9% Cons. · IFRS
FYE Mar 2025 5.3 +2222.3% Cons. · IFRS
FYE Mar 2026 3.5 −33.5% Cons. · IFRS
Definition
Costs arising outside the core business
Formula
Non-operating expenses line of the income statement
Source
Securities report (XBRL)

Net profit profit attributable to owners of the parent

FYE Mar 2026 ¥70bn
CAGR · 10 yrs +2.5%
Fiscal year Net profit ¥ bn YoY Basis
FYE Mar 2017 55.8 n/a Cons. · IFRS
FYE Mar 2018 50.3 −9.9% Cons. · IFRS
FYE Mar 2019 51.5 +2.5% Cons. · IFRS
FYE Mar 2020 59.7 +15.8% Cons. · IFRS
FYE Mar 2021 75.4 +26.3% Cons. · IFRS
FYE Mar 2022 80.5 +6.8% Cons. · IFRS
FYE Mar 2023 113 +40.0% Cons. · IFRS
FYE Mar 2024 128 +13.5% Cons. · IFRS
FYE Mar 2025 50.0 −60.9% Cons. · IFRS
FYE Mar 2026 69.8 +39.4% Cons. · IFRS
Definition
What is left after tax
Formula
Pre-tax profit − income taxes
Source
Securities report (XBRL)

Gross margin

FYE Mar 2026 72.5%
Average · 10 yrs 73.1%
Fiscal year Gross margin % YoY Basis
FYE Mar 2017 73.2 n/a Cons. · IFRS
FYE Mar 2018 75.0 +1.8pp Cons. · IFRS
FYE Mar 2019 71.0 −4.1pp Cons. · IFRS
FYE Mar 2020 73.0 +2.0pp Cons. · IFRS
FYE Mar 2021 72.3 −0.6pp Cons. · IFRS
FYE Mar 2022 74.1 +1.8pp Cons. · IFRS
FYE Mar 2023 75.4 +1.3pp Cons. · IFRS
FYE Mar 2024 74.7 −0.7pp Cons. · IFRS
FYE Mar 2025 69.6 −5.1pp Cons. · IFRS
FYE Mar 2026 72.5 +2.9pp Cons. · IFRS
Definition
The share of revenue left after the cost of sales
Formula
Gross profit ÷ revenue
Source
Securities report (XBRL)

Operating margin

FYE Mar 2026 17.9%
Average · 10 yrs 25.5%
Fiscal year Operating margin % YoY Basis
FYE Mar 2017 29.5 n/a Cons. · IFRS
FYE Mar 2018 23.2 −6.4pp Cons. · IFRS
FYE Mar 2019 21.5 −1.7pp Cons. · IFRS
FYE Mar 2020 26.5 +5.0pp Cons. · IFRS
FYE Mar 2021 31.8 +5.3pp Cons. · IFRS
FYE Mar 2022 28.6 −3.2pp Cons. · IFRS
FYE Mar 2023 31.7 +3.2pp Cons. · IFRS
FYE Mar 2024 31.8 +0.1pp Cons. · IFRS
FYE Mar 2025 12.3 −19.5pp Cons. · IFRS
FYE Mar 2026 17.9 +5.6pp Cons. · IFRS
Definition
The share of revenue the core business keeps
Formula
Operating profit ÷ revenue
Source
Securities report (XBRL)

Net margin

FYE Mar 2026 13.5%
Average · 10 yrs 20.1%
Fiscal year Net margin % YoY Basis
FYE Mar 2017 22.8 n/a Cons. · IFRS
FYE Mar 2018 19.2 −3.6pp Cons. · IFRS
FYE Mar 2019 17.9 −1.3pp Cons. · IFRS
FYE Mar 2020 20.4 +2.6pp Cons. · IFRS
FYE Mar 2021 24.4 +4.0pp Cons. · IFRS
FYE Mar 2022 22.3 −2.1pp Cons. · IFRS
FYE Mar 2023 25.2 +2.9pp Cons. · IFRS
FYE Mar 2024 25.5 +0.3pp Cons. · IFRS
FYE Mar 2025 10.3 −15.2pp Cons. · IFRS
FYE Mar 2026 13.5 +3.2pp Cons. · IFRS
Definition
The share of revenue left after everything
Formula
Net profit ÷ revenue
Source
Securities report (XBRL)

Cost-of-sales ratio

FYE Mar 2026 27.5%
Average · 10 yrs 26.9%
Fiscal year Cost-of-sales ratio % YoY Basis
FYE Mar 2017 26.8 n/a Cons. · IFRS
FYE Mar 2018 25.0 −1.8pp Cons. · IFRS
FYE Mar 2019 29.0 +4.1pp Cons. · IFRS
FYE Mar 2020 27.0 −2.0pp Cons. · IFRS
FYE Mar 2021 27.7 +0.6pp Cons. · IFRS
FYE Mar 2022 25.9 −1.8pp Cons. · IFRS
FYE Mar 2023 24.6 −1.3pp Cons. · IFRS
FYE Mar 2024 25.3 +0.7pp Cons. · IFRS
FYE Mar 2025 30.4 +5.1pp Cons. · IFRS
FYE Mar 2026 27.5 −2.9pp Cons. · IFRS
Definition
The share of revenue taken by the cost of sales
Formula
Cost of sales ÷ revenue
Source
Securities report (XBRL)

SG&A ratio

FYE Mar 2026 24.0%
Average · 10 yrs 23.2%
Fiscal year SG&A ratio % YoY Basis
FYE Mar 2017 25.3 n/a Cons. · IFRS
FYE Mar 2018 26.0 +0.6pp Cons. · IFRS
FYE Mar 2019 24.3 −1.7pp Cons. · IFRS
FYE Mar 2020 23.1 −1.1pp Cons. · IFRS
FYE Mar 2021 22.4 −0.8pp Cons. · IFRS
FYE Mar 2022 21.3 −1.1pp Cons. · IFRS
FYE Mar 2023 20.0 −1.3pp Cons. · IFRS
FYE Mar 2024 19.9 −0.1pp Cons. · IFRS
FYE Mar 2025 25.8 +5.9pp Cons. · IFRS
FYE Mar 2026 24.0 −1.8pp Cons. · IFRS
Definition
The share of revenue taken by selling and administrative costs
Formula
SG&A ÷ revenue
Source
Securities report (XBRL)

Balance sheet Assets, debt and equity, and what they say about financial strength

What the balance sheet is made of

¥ bn
Equity Liabilities and non-controlling interests

Financial strength

%
Equity ratio Debt-to-equity

Total assets

FYE Mar 2026 ¥1.11tn
CAGR · 10 yrs +6.7%
Fiscal year Total assets ¥ bn YoY Basis
FYE Mar 2017 617 n/a Cons. · IFRS
FYE Mar 2018 609 −1.3% Cons. · IFRS
FYE Mar 2019 655 +7.5% Cons. · IFRS
FYE Mar 2020 673 +2.8% Cons. · IFRS
FYE Mar 2021 745 +10.7% Cons. · IFRS
FYE Mar 2022 739 −0.8% Cons. · IFRS
FYE Mar 2023 882 +19.4% Cons. · IFRS
FYE Mar 2024 914 +3.5% Cons. · IFRS
FYE Mar 2025 1,064 +16.5% Cons. · IFRS
FYE Mar 2026 1,107 +4.0% Cons. · IFRS
Definition
Everything the company holds
Formula
Total assets line of the balance sheet
Source
Securities report (XBRL)

Equity net assets, shareholders' equity

FYE Mar 2026 ¥845bn
CAGR · 10 yrs +5.6%
Fiscal year Equity ¥ bn YoY Basis
FYE Mar 2017 519 n/a Cons. · IFRS
FYE Mar 2018 519 −0.0% Cons. · IFRS
FYE Mar 2019 552 +6.3% Cons. · IFRS
FYE Mar 2020 557 +0.9% Cons. · IFRS
FYE Mar 2021 629 +12.9% Cons. · IFRS
FYE Mar 2022 650 +3.4% Cons. · IFRS
FYE Mar 2023 736 +13.2% Cons. · IFRS
FYE Mar 2024 787 +7.0% Cons. · IFRS
FYE Mar 2025 777 −1.3% Cons. · IFRS
FYE Mar 2026 845 +8.8% Cons. · IFRS
Definition
The part of the funding that never has to be repaid
Formula
Net assets line of the balance sheet
Source
Securities report (XBRL)

Interest-bearing debt

FYE Mar 2026 ¥110bn
CAGR · 6 yrs +174.2%
Fiscal year Interest-bearing debt ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 0.7 n/a Cons. · IFRS
FYE Mar 2019 2.2 +209.0% Cons. · IFRS
FYE Mar 2020 0.0 −100.0% Cons. · IFRS
FYE Mar 2021 n/a n/a Cons. · IFRS
FYE Mar 2022 n/a n/a Cons. · IFRS
FYE Mar 2023 n/a n/a Cons. · IFRS
FYE Mar 2024 0.0 n/a Cons. · IFRS
FYE Mar 2025 135 n/a Cons. · IFRS
FYE Mar 2026 110 −18.2% Cons. · IFRS
Definition
Borrowings the company pays interest on
Formula
Loans + bonds + lease obligations
Source
Securities report (XBRL)

Short-term borrowings

FYE Mar 2026 ¥35bn
CAGR · 4 yrs +348.6%
Fiscal year Short-term borrowings ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 0.4 n/a Cons. · IFRS
FYE Mar 2019 0.4 +11.0% Cons. · IFRS
FYE Mar 2020 n/a n/a Cons. · IFRS
FYE Mar 2021 n/a n/a Cons. · IFRS
FYE Mar 2022 n/a n/a Cons. · IFRS
FYE Mar 2023 n/a n/a Cons. · IFRS
FYE Mar 2024 n/a n/a Cons. · IFRS
FYE Mar 2025 30.0 n/a Cons. · IFRS
FYE Mar 2026 35.4 +18.0% Cons. · IFRS
Definition
Borrowings repayable within a year
Formula
Short-term borrowings line of the balance sheet
Source
Securities report (XBRL)

Long-term borrowings

FYE Mar 2026 ¥75bn
CAGR · 4 yrs +516.6%
Fiscal year Long-term borrowings ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 0.3 n/a Cons. · IFRS
FYE Mar 2019 1.8 +451.6% Cons. · IFRS
FYE Mar 2020 n/a n/a Cons. · IFRS
FYE Mar 2021 n/a n/a Cons. · IFRS
FYE Mar 2022 n/a n/a Cons. · IFRS
FYE Mar 2023 n/a n/a Cons. · IFRS
FYE Mar 2024 n/a n/a Cons. · IFRS
FYE Mar 2025 105 n/a Cons. · IFRS
FYE Mar 2026 75.0 −28.6% Cons. · IFRS
Definition
Borrowings repayable in more than a year
Formula
Long-term borrowings line of the balance sheet
Source
Securities report (XBRL)

Intangible assets

FYE Mar 2026 ¥354bn
CAGR · 9 yrs +26.0%
Fiscal year Intangible assets ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 55.7 n/a Cons. · IFRS
FYE Mar 2019 63.1 +13.2% Cons. · IFRS
FYE Mar 2020 66.4 +5.4% Cons. · IFRS
FYE Mar 2021 68.3 +2.8% Cons. · IFRS
FYE Mar 2022 64.7 −5.2% Cons. · IFRS
FYE Mar 2023 69.1 +6.8% Cons. · IFRS
FYE Mar 2024 57.3 −17.1% Cons. · IFRS
FYE Mar 2025 330 +476.1% Cons. · IFRS
FYE Mar 2026 354 +7.1% Cons. · IFRS
Definition
Assets with no physical form
Formula
Intangible assets line of the balance sheet
Source
Securities report (XBRL)

Equity ratio

FYE Mar 2026 76.3%
Average · 10 yrs 82.7%
Fiscal year Equity ratio % YoY Basis
FYE Mar 2017 84.1 n/a Cons. · IFRS
FYE Mar 2018 85.2 +1.1pp Cons. · IFRS
FYE Mar 2019 84.3 −1.0pp Cons. · IFRS
FYE Mar 2020 82.7 −1.6pp Cons. · IFRS
FYE Mar 2021 84.3 +1.6pp Cons. · IFRS
FYE Mar 2022 88.0 +3.6pp Cons. · IFRS
FYE Mar 2023 83.4 −4.6pp Cons. · IFRS
FYE Mar 2024 86.2 +2.8pp Cons. · IFRS
FYE Mar 2025 73.0 −13.2pp Cons. · IFRS
FYE Mar 2026 76.3 +3.4pp Cons. · IFRS
Definition
How much of the balance sheet is funded without debt
Formula
Equity ÷ total assets
Source
Securities report (XBRL)

Debt-to-equity ratio D/E ratio

FYE Mar 2026 13.1%
Average · 6 yrs 5.2%
Fiscal year Debt-to-equity ratio % YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 0.1 n/a Cons. · IFRS
FYE Mar 2019 0.4 +0.3pp Cons. · IFRS
FYE Mar 2020 0.0 −0.4pp Cons. · IFRS
FYE Mar 2021 n/a n/a Cons. · IFRS
FYE Mar 2022 n/a n/a Cons. · IFRS
FYE Mar 2023 n/a n/a Cons. · IFRS
FYE Mar 2024 0.0 n/a Cons. · IFRS
FYE Mar 2025 17.4 +17.4pp Cons. · IFRS
FYE Mar 2026 13.1 −4.3pp Cons. · IFRS
Definition
Borrowings measured against the company's own capital
Formula
Interest-bearing debt ÷ equity
Source
Securities report (XBRL)

ROE return on equity

FYE Mar 2026 8.3%
Average · 10 yrs 11.1%
Fiscal year ROE % YoY Basis
FYE Mar 2017 10.7 n/a Cons. · IFRS
FYE Mar 2018 9.7 −1.1pp Cons. · IFRS
FYE Mar 2019 9.3 −0.3pp Cons. · IFRS
FYE Mar 2020 10.7 +1.4pp Cons. · IFRS
FYE Mar 2021 12.0 +1.3pp Cons. · IFRS
FYE Mar 2022 12.4 +0.4pp Cons. · IFRS
FYE Mar 2023 15.3 +2.9pp Cons. · IFRS
FYE Mar 2024 16.3 +0.9pp Cons. · IFRS
FYE Mar 2025 6.4 −9.8pp Cons. · IFRS
FYE Mar 2026 8.3 +1.8pp Cons. · IFRS
Definition
What the shareholders' capital earns
Formula
Net profit ÷ equity
Source
Securities report (XBRL)

ROA return on assets

FYE Mar 2026 6.3%
Average · 10 yrs 9.3%
Fiscal year ROA % YoY Basis
FYE Mar 2017 9.0 n/a Cons. · IFRS
FYE Mar 2018 8.3 −0.8pp Cons. · IFRS
FYE Mar 2019 7.9 −0.4pp Cons. · IFRS
FYE Mar 2020 8.9 +1.0pp Cons. · IFRS
FYE Mar 2021 10.1 +1.3pp Cons. · IFRS
FYE Mar 2022 10.9 +0.8pp Cons. · IFRS
FYE Mar 2023 12.8 +1.9pp Cons. · IFRS
FYE Mar 2024 14.0 +1.2pp Cons. · IFRS
FYE Mar 2025 4.7 −9.3pp Cons. · IFRS
FYE Mar 2026 6.3 +1.6pp Cons. · IFRS
Definition
What the whole balance sheet earns
Formula
Net profit ÷ total assets
Source
Securities report (XBRL)

Asset turnover

FYE Mar 2026 0.47×
CAGR · 10 yrs +1.8%
Fiscal year Asset turnover × YoY Basis
FYE Mar 2017 0.40 n/a Cons. · IFRS
FYE Mar 2018 0.43 +8.4% Cons. · IFRS
FYE Mar 2019 0.44 +2.5% Cons. · IFRS
FYE Mar 2020 0.43 −1.5% Cons. · IFRS
FYE Mar 2021 0.41 −4.4% Cons. · IFRS
FYE Mar 2022 0.49 +17.8% Cons. · IFRS
FYE Mar 2023 0.51 +3.7% Cons. · IFRS
FYE Mar 2024 0.55 +8.6% Cons. · IFRS
FYE Mar 2025 0.46 −16.8% Cons. · IFRS
FYE Mar 2026 0.47 +1.9% Cons. · IFRS
Definition
How much revenue each yen of assets produces
Formula
Revenue ÷ total assets
Source
Securities report (XBRL)

Cash flow statement Cash from operations, investment and financing, and what is left on hand

The three cash flows

¥ bn
Operating CF Investing CF Financing CF

Cash against debt

¥ bn
Cash and equivalents Interest-bearing debt Net cash

Operating cash flow

FYE Mar 2026 ¥137bn
CAGR · 10 yrs +7.0%
Fiscal year Operating cash flow ¥ bn YoY Basis
FYE Mar 2017 74.5 n/a Cons. · IFRS
FYE Mar 2018 15.7 −78.9% Cons. · IFRS
FYE Mar 2019 66.8 +324.6% Cons. · IFRS
FYE Mar 2020 74.2 +11.1% Cons. · IFRS
FYE Mar 2021 74.0 −0.2% Cons. · IFRS
FYE Mar 2022 61.8 −16.4% Cons. · IFRS
FYE Mar 2023 160 +158.1% Cons. · IFRS
FYE Mar 2024 111 −30.7% Cons. · IFRS
FYE Mar 2025 82.5 −25.5% Cons. · IFRS
FYE Mar 2026 137 +65.9% Cons. · IFRS
Definition
Cash the business itself generated
Formula
Cash flow from operating activities
Source
Securities report (XBRL)

Investing cash flow

FYE Mar 2026 -¥40bn
Average · 10 yrs -¥39bn
Fiscal year Investing cash flow ¥ bn YoY Basis
FYE Mar 2017 -18.0 n/a Cons. · IFRS
FYE Mar 2018 -34.2 n/a Cons. · IFRS
FYE Mar 2019 -49.8 n/a Cons. · IFRS
FYE Mar 2020 -10.2 n/a Cons. · IFRS
FYE Mar 2021 -57.6 n/a Cons. · IFRS
FYE Mar 2022 6.0 n/a Cons. · IFRS
FYE Mar 2023 -100 −1760.5% Cons. · IFRS
FYE Mar 2024 48.1 n/a Cons. · IFRS
FYE Mar 2025 -137 −384.5% Cons. · IFRS
FYE Mar 2026 -39.9 n/a Cons. · IFRS
Definition
Cash spent on, or released by, investment
Formula
Cash flow from investing activities
Source
Securities report (XBRL)

Financing cash flow

FYE Mar 2026 -¥65bn
Average · 10 yrs -¥34bn
Fiscal year Financing cash flow ¥ bn YoY Basis
FYE Mar 2017 -20.6 n/a Cons. · IFRS
FYE Mar 2018 -62.5 n/a Cons. · IFRS
FYE Mar 2019 -22.3 n/a Cons. · IFRS
FYE Mar 2020 -54.7 n/a Cons. · IFRS
FYE Mar 2021 -24.8 n/a Cons. · IFRS
FYE Mar 2022 -60.2 n/a Cons. · IFRS
FYE Mar 2023 -32.5 n/a Cons. · IFRS
FYE Mar 2024 -89.8 n/a Cons. · IFRS
FYE Mar 2025 94.3 n/a Cons. · IFRS
FYE Mar 2026 -65.5 −169.5% Cons. · IFRS
Definition
Cash raised from, or returned to, lenders and shareholders
Formula
Cash flow from financing activities
Source
Securities report (XBRL)

Cash and equivalents

FYE Mar 2026 ¥237bn
CAGR · 10 yrs +5.5%
Fiscal year Cash and equivalents ¥ bn YoY Basis
FYE Mar 2017 146 n/a Cons. · IFRS
FYE Mar 2018 65.3 −55.4% Cons. · IFRS
FYE Mar 2019 60.0 −8.1% Cons. · IFRS
FYE Mar 2020 69.0 +15.0% Cons. · IFRS
FYE Mar 2021 61.0 −11.5% Cons. · IFRS
FYE Mar 2022 69.1 +13.2% Cons. · IFRS
FYE Mar 2023 96.1 +39.1% Cons. · IFRS
FYE Mar 2024 166 +72.8% Cons. · IFRS
FYE Mar 2025 205 +23.1% Cons. · IFRS
FYE Mar 2026 237 +15.9% Cons. · IFRS
Definition
Cash on hand at the year end
Formula
Closing balance in the cash flow statement
Source
Securities report (XBRL)

Free cash flow

FYE Mar 2026 ¥97bn
CAGR · 10 yrs +6.2%
Fiscal year FCF ¥ bn YoY Basis
FYE Mar 2017 56.5 n/a Cons. · IFRS
FYE Mar 2018 -18.5 −132.7% Cons. · IFRS
FYE Mar 2019 17.0 n/a Cons. · IFRS
FYE Mar 2020 63.9 +275.8% Cons. · IFRS
FYE Mar 2021 16.4 −74.4% Cons. · IFRS
FYE Mar 2022 67.9 +314.1% Cons. · IFRS
FYE Mar 2023 59.4 −12.5% Cons. · IFRS
FYE Mar 2024 159 +167.5% Cons. · IFRS
FYE Mar 2025 -54.3 −134.2% Cons. · IFRS
FYE Mar 2026 97.0 n/a Cons. · IFRS
Definition
What is left once the business has paid for its own investment
Formula
Operating cash flow + investing cash flow
Source
Securities report (XBRL)

Operating cash flow margin

FYE Mar 2026 26.5%
Average · 10 yrs 22.7%
Fiscal year OCF margin % YoY Basis
FYE Mar 2017 30.4 n/a Cons. · IFRS
FYE Mar 2018 6.0 −24.4pp Cons. · IFRS
FYE Mar 2019 23.1 +17.1pp Cons. · IFRS
FYE Mar 2020 25.4 +2.2pp Cons. · IFRS
FYE Mar 2021 23.9 −1.4pp Cons. · IFRS
FYE Mar 2022 17.1 −6.8pp Cons. · IFRS
FYE Mar 2023 35.7 +18.6pp Cons. · IFRS
FYE Mar 2024 22.0 −13.7pp Cons. · IFRS
FYE Mar 2025 16.9 −5.1pp Cons. · IFRS
FYE Mar 2026 26.5 +9.6pp Cons. · IFRS
Definition
How much of the revenue turned into cash
Formula
Operating cash flow ÷ revenue
Source
Securities report (XBRL)

Net cash

FYE Mar 2026 ¥127bn
CAGR · 6 yrs +14.4%
Fiscal year Net cash ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 64.6 n/a Cons. · IFRS
FYE Mar 2019 57.8 −10.5% Cons. · IFRS
FYE Mar 2020 69.0 +19.4% Cons. · IFRS
FYE Mar 2021 n/a n/a Cons. · IFRS
FYE Mar 2022 n/a n/a Cons. · IFRS
FYE Mar 2023 n/a n/a Cons. · IFRS
FYE Mar 2024 166 n/a Cons. · IFRS
FYE Mar 2025 69.6 −58.1% Cons. · IFRS
FYE Mar 2026 127 +82.1% Cons. · IFRS
Definition
Cash on hand once the borrowings are paid off
Formula
Cash and equivalents − interest-bearing debt
Source
Securities report (XBRL)

Shares and share price Shares outstanding, price, market capitalisation and the valuation multiples

Market capitalisation

FYE Mar 2026 ¥1.25tn
Change · 10 yrs −¥107bn
Fiscal year Market capitalisation ¥ bn Basis
FYE Mar 2017 1,358 n/a
FYE Mar 2018 1,792 n/a
FYE Mar 2019 1,177 n/a
FYE Mar 2020 1,314 n/a
FYE Mar 2021 1,525 n/a
FYE Mar 2022 1,620 n/a
FYE Mar 2023 1,433 n/a
FYE Mar 2024 1,223 n/a
FYE Mar 2025 797 n/a
FYE Mar 2026 1,251 n/a
Definition
What the market says the company is worth
Formula
Year-end share price × shares outstanding
Source
Securities report (XBRL)

Share price year-end close

FYE Mar 2026 2,509¥
Change · 10 yrs +204¥
Fiscal year Share price ¥ Basis
FYE Mar 2017 2,305 n/a
FYE Mar 2018 3,298 n/a
FYE Mar 2019 2,165 n/a
FYE Mar 2020 2,488 n/a
FYE Mar 2021 2,886 n/a
FYE Mar 2022 3,065 n/a
FYE Mar 2023 2,770 n/a
FYE Mar 2024 2,453 n/a
FYE Mar 2025 1,598 n/a
FYE Mar 2026 2,509 n/a
Definition
The closing price on the last day of the fiscal year
Formula
Year-end closing price
Source
Securities report (XBRL)

Shares outstanding

FYE Mar 2026 498,692,000shares
Change · 10 yrs −90,545,000 shares
Fiscal year Shares outstanding shares Basis
FYE Mar 2017 589,237,000 Parent
FYE Mar 2018 543,341,000 Parent
FYE Mar 2019 543,341,000 Parent
FYE Mar 2020 528,341,000 Parent
FYE Mar 2021 528,341,000 Parent
FYE Mar 2022 528,341,000 Parent
FYE Mar 2023 517,425,000 Parent
FYE Mar 2024 498,692,000 Parent
FYE Mar 2025 498,692,000 Parent
FYE Mar 2026 498,692,000 Parent
Definition
How many shares exist
Formula
Shares issued, from the key figures of the filing
Source
Securities report (XBRL)

EPS earnings per share

FYE Mar 2026 148.49¥
Change · 10 yrs +43.22¥
Fiscal year EPS ¥ Basis
FYE Mar 2017 105.27 Cons.
FYE Mar 2018 97.00 Cons.
FYE Mar 2019 100.25 Cons.
FYE Mar 2020 118.47 Cons.
FYE Mar 2021 151.11 Cons.
FYE Mar 2022 162.19 Cons.
FYE Mar 2023 230.85 Cons.
FYE Mar 2024 266.61 Cons.
FYE Mar 2025 106.55 Cons.
FYE Mar 2026 148.49 Cons.
Definition
Net profit for each share
Formula
Net profit ÷ average shares outstanding
Source
Securities report (XBRL)

BPS book value per share

FYE Mar 2026 1,694.05¥
Change · 10 yrs +813.06¥
Fiscal year BPS ¥ Basis
FYE Mar 2017 880.99 Cons. · IFRS
FYE Mar 2018 955.50 Cons. · IFRS
FYE Mar 2019 1,015.87 Cons. · IFRS
FYE Mar 2020 1,054.14 Cons. · IFRS
FYE Mar 2021 1,189.62 Cons. · IFRS
FYE Mar 2022 1,230.53 Cons. · IFRS
FYE Mar 2023 1,422.28 Cons. · IFRS
FYE Mar 2024 1,578.76 Cons. · IFRS
FYE Mar 2025 1,557.47 Cons. · IFRS
FYE Mar 2026 1,694.05 Cons. · IFRS
Definition
Equity behind each share
Formula
Equity ÷ shares outstanding
Source
Securities report (XBRL)

PER price-to-earnings ratio

FYE Mar 2026 16.90×
Average · 10 yrs 18.96×
Fiscal year PER × Basis
FYE Mar 2017 21.90 Cons.
FYE Mar 2018 34.00 Cons.
FYE Mar 2019 21.60 Cons.
FYE Mar 2020 21.00 Cons.
FYE Mar 2021 19.10 Cons.
FYE Mar 2022 18.90 Cons.
FYE Mar 2023 12.00 Cons.
FYE Mar 2024 9.20 Cons.
FYE Mar 2025 15.00 Cons.
FYE Mar 2026 16.90 Cons.
Definition
How many years of earnings the price stands for
Formula
Year-end price ÷ EPS
Source
Securities report (XBRL)

PBR price-to-book ratio

FYE Mar 2026 1.39×
Average · 10 yrs 2.00×
Fiscal year PBR × Basis
FYE Mar 2017 2.35 Cons.
FYE Mar 2018 3.23 Cons.
FYE Mar 2019 2.00 Cons.
FYE Mar 2020 2.21 Cons.
FYE Mar 2021 2.27 Cons.
FYE Mar 2022 2.28 Cons.
FYE Mar 2023 1.82 Cons.
FYE Mar 2024 1.45 Cons.
FYE Mar 2025 0.96 Cons.
FYE Mar 2026 1.39 Cons.
Definition
The price measured against the book value behind it
Formula
Year-end price ÷ BPS
Source
Securities report (XBRL)

Workforce and productivity Headcount, pay and what each employee accounts for

Group employees

FYE Mar 2026 4,206people
Change · 10 yrs +916 people
Fiscal year Group employees people YoY Basis
FYE Mar 2017 3,290 n/a Cons.
FYE Mar 2018 3,480 +5.8% Cons.
FYE Mar 2019 3,555 +2.2% Cons.
FYE Mar 2020 3,560 +0.1% Cons.
FYE Mar 2021 3,607 +1.3% Cons.
FYE Mar 2022 3,687 +2.2% Cons.
FYE Mar 2023 3,761 +2.0% Cons.
FYE Mar 2024 3,853 +2.4% Cons.
FYE Mar 2025 4,287 +11.3% Cons.
FYE Mar 2026 4,206 −1.9% Cons.
Definition
Everyone employed across the group
Formula
Consolidated headcount, from the employee section of the filing
Source
Securities report (XBRL)

Parent-company employees

FYE Mar 2026 3,396people
Change · 10 yrs +334 people
Fiscal year Parent-company employees people YoY Basis
FYE Mar 2017 3,062 n/a Parent
FYE Mar 2018 3,199 +4.5% Parent
FYE Mar 2019 3,284 +2.7% Parent
FYE Mar 2020 3,287 +0.1% Parent
FYE Mar 2021 3,319 +1.0% Parent
FYE Mar 2022 3,354 +1.1% Parent
FYE Mar 2023 3,381 +0.8% Parent
FYE Mar 2024 3,437 +1.7% Parent
FYE Mar 2025 3,464 +0.8% Parent
FYE Mar 2026 3,396 −2.0% Parent
Definition
Employees of the filing company itself
Formula
Parent-only headcount, from the employee section of the filing
Source
Securities report (XBRL)

Average annual pay parent company

FYE Mar 2026 1,094万円
Change · 8 yrs +177万円
Fiscal year Average annual pay 万円 YoY Basis
FYE Mar 2017 n/a n/a Parent
FYE Mar 2018 n/a n/a Parent
FYE Mar 2019 917 n/a Parent
FYE Mar 2020 928 +1.2% Parent
FYE Mar 2021 937 +1.0% Parent
FYE Mar 2022 947 +1.1% Parent
FYE Mar 2023 963 +1.6% Parent
FYE Mar 2024 987 +2.5% Parent
FYE Mar 2025 1,017 +3.1% Parent
FYE Mar 2026 1,094 +7.5% Parent
Definition
Average total annual compensation, bonuses included
Formula
Average annual pay, from the employee section of the filing
Source
Securities report (XBRL)

Average age

FYE Mar 2026 43.7years
Change · 8 yrs +1.9 years
Fiscal year Average age years YoY Basis
FYE Mar 2017 n/a n/a Parent
FYE Mar 2018 n/a n/a Parent
FYE Mar 2019 41.8 n/a Parent
FYE Mar 2020 41.9 +0.2% Parent
FYE Mar 2021 42.6 +1.7% Parent
FYE Mar 2022 43.0 +0.9% Parent
FYE Mar 2023 43.5 +1.2% Parent
FYE Mar 2024 43.8 +0.7% Parent
FYE Mar 2025 44.2 +0.9% Parent
FYE Mar 2026 43.7 −1.1% Parent
Definition
Average age of the parent company's employees
Formula
Average age, from the employee section of the filing
Source
Securities report (XBRL)

Average length of service

FYE Mar 2026 17.4years
Change · 8 yrs +1.9 years
Fiscal year Average length of service years YoY Basis
FYE Mar 2017 n/a n/a Parent
FYE Mar 2018 n/a n/a Parent
FYE Mar 2019 15.5 n/a Parent
FYE Mar 2020 15.0 −3.2% Parent
FYE Mar 2021 16.3 +8.7% Parent
FYE Mar 2022 16.5 +1.2% Parent
FYE Mar 2023 16.8 +1.8% Parent
FYE Mar 2024 16.8 −0.0% Parent
FYE Mar 2025 16.9 +0.6% Parent
FYE Mar 2026 17.4 +3.0% Parent
Definition
How long the average employee has been with the company
Formula
Average years of service, from the employee section of the filing
Source
Securities report (XBRL)

Revenue per employee

FYE Mar 2026 ¥123m
Change · 10 yrs +¥48.2m
Fiscal year Revenue per employee ¥ m YoY Basis
FYE Mar 2017 74.4 n/a Cons.
FYE Mar 2018 75.2 +1.1% Cons.
FYE Mar 2019 81.2 +7.9% Cons.
FYE Mar 2020 82.1 +1.2% Cons.
FYE Mar 2021 85.7 +4.4% Cons.
FYE Mar 2022 98.0 +14.3% Cons.
FYE Mar 2023 119 +21.3% Cons.
FYE Mar 2024 130 +9.7% Cons.
FYE Mar 2025 114 −12.9% Cons.
FYE Mar 2026 123 +8.0% Cons.
Definition
What each employee accounts for in revenue
Formula
Revenue ÷ group employees
Source
Securities report (XBRL)

Operating profit per employee

FYE Mar 2026 ¥21.9m
Change · 10 yrs −¥0.0m
Fiscal year OP per employee ¥ m YoY Basis
FYE Mar 2017 22.0 n/a Cons.
FYE Mar 2018 17.4 −20.6% Cons.
FYE Mar 2019 17.4 −0.0% Cons.
FYE Mar 2020 21.8 +24.8% Cons.
FYE Mar 2021 27.3 +25.2% Cons.
FYE Mar 2022 28.0 +2.7% Cons.
FYE Mar 2023 37.7 +34.9% Cons.
FYE Mar 2024 41.5 +10.0% Cons.
FYE Mar 2025 13.9 −66.4% Cons.
FYE Mar 2026 21.9 +57.4% Cons.
Definition
What each employee accounts for in operating profit
Formula
Operating profit ÷ group employees
Source
Securities report (XBRL)

Disclaimer

Accuracy, liability, reuse and privacy — the full disclaimer →

Data API

Ono Pharmaceutical’s history, presidents and financials are published as static JSON — no key, plain GET. One API per public page, and one per section where a page carries several tables. Full specification →

/api/4528/company.json ·/api/4528/history.json ·/api/4528/ceo.json ·/api/4528/financials.json ·/api/4528/financials/segment.json ·/api/4528/financials/pl.json ·/api/4528/financials/cf.json ·/api/4528/financials/bs.json ·/api/4528/financials/employee.json ·/api/4528/financials/stock.json ·/api/4528/financials.csv ·/api/4528/financials_history.csv

/api/companies.json ·/api/decisions.json ·/api/api-manifest.json